Transmitted NNRTI resistance does not impact the efficacy of EVG/c/FTC/TAF (or TDF) in two randomised clinical trials in treatment-naive patients living with HIV-1

被引：0
|
作者：
Mackie, N. [1 ]
Antonucci, S. [2 ]
Rogatto, F. [3 ]
Callebaut, C. [4 ]
Margot, N. [4 ]
机构：
[1] St Marys Imperial Coll Healthcare, London, England
[2] Gilead Sci, London, England
[3] Gilead Sci, EMEAC, London, England
[4] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P20
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [1] Integrated analysis of emergent drug resistance through 48 weeks from clinical studies of HIV-1 treatment-naive subjects receiving EVG/COBI/FTC/TAF
    Kitrinos, K. M.
    Fordyce, M. W.
    McCallister, S.
    Miller, M. D.
    Callebaut, C.
    Margot, N. A.
    Yau, S.
    HIV MEDICINE, 2015, 16 : 14 - 14
  • [2] Safety and efficacy of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) in treatment-naive HIV-1 infected adults with transmitted NNRTI resistance mutations
    Wong, A.
    Goldstein, D.
    Mallolas, J.
    DeJesus, E.
    Johnson, M.
    Molina, J.
    Pozniak, A.
    Rodgers, A.
    Teal, V.
    Hepler, D.
    Kumar, S.
    Sklar, P.
    Hanna, G.
    Hwang, C.
    Badshah, C.
    Teppler, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [3] Virological outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in antiretroviral-naive HIV-1-infected participants with baseline HIV-1 RNA ≥1,000,000 copies/ml: a post hoc analysis of Phase III clinical trials
    Sax, Paul
    DeJesus, Edwin
    Wohl, David
    DeMorin, Jennifer
    McColl, Damian
    Piontkowsky, David
    Cohen, Calvin
    Wang, Hui
    White, Kirsten
    Callebaut, Christian
    Rhee, Martin
    Das, Moupali
    Quirk, Erin
    ANTIVIRAL THERAPY, 2018, 23 (01) : 95 - 99
  • [4] Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing
    Song, Y. X.
    Xin, R. L.
    Li, Z. C.
    Yu, H. W.
    Lun, W. H.
    Ye, J.
    Liu, A.
    Li, A. X.
    Li, J. W.
    Ye, J. Z.
    Hao, M. Q.
    Lu, H. Y.
    Sun, L. J.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (03): : 339 - 344
  • [5] High levels of resistance among HIV-1 treatment-naive PLHIV in Greece: Evidence for ongoing NNRTI transmitted resistance within local transmission networks
    Paraskevis, D.
    Papachristou, E.
    Kostaki, E. G.
    Vasilakis, A.
    Chini, M.
    Tsekes, G.
    Antoniadou, A.
    Papadopoulos, A.
    Bletsa, M.
    Sotiriadou, F.
    Psichogiou, M.
    Mastrogianni, E.
    Papastamopoulos, V.
    Totsikas, C.
    Adamis, G.
    Astriti, M.
    Paraskeva, D.
    Tsiara, C.
    Isari, A.
    Giannou, F.
    Pylli, M.
    Sipsas, N.
    Kosmopoulou, O.
    Chrysos, G.
    Sambatakou, H.
    Lada, M.
    Panagopoulos, P.
    Lagiou, P.
    Magiorkinis, G.
    HIV MEDICINE, 2023, 24 : 372 - 373
  • [6] Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials
    Cohen, Calvin J.
    Molina, Jean-Michel
    Cassetti, Isabel
    Chetchotisakd, Ploenchan
    Lazzarin, Adriano
    Orkin, Chloe
    Rhame, Frank
    Stellbrink, Hans-Juergen
    Li, Taisheng
    Crauwels, Herta
    Rimsky, Laurence
    Vanveggel, Simon
    Williams, Peter
    Boven, Katia
    AIDS, 2013, 27 (06) : 939 - 950
  • [7] Baseline Antiretroviral Resistance Mutations and Treatment-Emergent Resistance in HIV-1 RNA-Suppressed Patients Switching to EVG/COBI/FTC/TDF or Continuing on Their PI-, NNRTI-, or RAL-Based Regimen
    Andreatta, Kristen
    Kulkarni, Rima
    Abram, Michael E.
    Thai Nguyen
    Cao, Huyen
    Miller, Michael D.
    White, Kirsten L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 519 - 526
  • [8] Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV plus RTV plus FTC/TDF in HIV-1-infected treatment-naive subjects ≥50 years
    Gazzard, Brian
    Girard, Pierre Marie
    Di Perri, Giovanni
    Gallant, Joel
    Towner, William
    Rogatto, Felipe
    Demorin, Jennifer
    McColl, Damian
    Liu, Hui
    Rhee, Martin
    Szwarcberg, Javier
    Piontkowsky, David
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 167 - 167
  • [9] COST EFFECTIVENESS ANALYSIS OF DTG/3TC VERSUS EVG/C/TARIFTC AND BIC/TAF/FTC FOR HIV-I INFECTION MANAGEMENT IN TREATMENT-NAIVE PATIENTS IN CHINA
    Fan, L.
    Tang, Z.
    Anderson, S. J.
    Evitt, L.
    Jacob, I
    Shiri, T.
    Turner, M.
    Tewary, A.
    VALUE IN HEALTH, 2022, 25 (12) : S132 - S133
  • [10] High HIV-1 genetic diversity and low prevalence of transmitted drug resistance among treatment-naive people living with HIV in Madagascar
    Rakotomalala, Fetra Angelot
    Butel, Christelle
    Rasamoelina, Tahinamandranto
    Serrano, Laetitia
    Vidal, Nicole
    Randriarimanana, Santatriniaina Hajanirina Dauphin
    Maharavo, Luca
    Randriamananjara, Hajanirina Nathanaella
    Fernandez-Nunez, Nicolas
    Rabetokotany, Felana Ranaivo
    Rakoto, Danielle Aurore Doll
    Delaporte, Eric
    Peeters, Martine
    Babin, Francois-Xavier
    Samison, Luc Herve
    Nerrienet, Eric
    Ayouba, Ahidjo
    INFECTION GENETICS AND EVOLUTION, 2024, 125
12345